Ching‐Yuan Wu

1.9k total citations · 1 hit paper
94 papers, 1.5k citations indexed

About

Ching‐Yuan Wu is a scholar working on Electrical and Electronic Engineering, Atomic and Molecular Physics, and Optics and Infectious Diseases. According to data from OpenAlex, Ching‐Yuan Wu has authored 94 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Electrical and Electronic Engineering, 21 papers in Atomic and Molecular Physics, and Optics and 15 papers in Infectious Diseases. Recurrent topics in Ching‐Yuan Wu's work include Semiconductor materials and devices (29 papers), Advancements in Semiconductor Devices and Circuit Design (25 papers) and Semiconductor materials and interfaces (15 papers). Ching‐Yuan Wu is often cited by papers focused on Semiconductor materials and devices (29 papers), Advancements in Semiconductor Devices and Circuit Design (25 papers) and Semiconductor materials and interfaces (15 papers). Ching‐Yuan Wu collaborates with scholars based in Taiwan, China and United States. Ching‐Yuan Wu's co-authors include Yao‐Hsu Yang, Yu‐Ching Cheng, Li‐Hsin Shu, Yu‐Shih Lin, Cheng‐Ming Hsu, Ming‐Shao Tsai, Jrhau Lung, Geng‐He Chang, Hong‐Yo Kang and Ming‐Jer Chen and has published in prestigious journals such as Applied Physics Letters, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Ching‐Yuan Wu

92 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase

2020 225 citations Jrhau Lung, Yu‐Shih Lin et al. Journal of Medical Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching‐Yuan Wu Taiwan	21	494	298	248	232	208	94	1.5k
Baiqing Li China	23	107 0.2×	254 0.9×	190 0.8×	168 0.7×	94 0.5×	110	1.9k
Shuiqing Hu China	23	146 0.3×	667 2.2×	217 0.9×	451 1.9×	69 0.3×	66	2.1k
Sung Hwan Kim South Korea	23	777 1.6×	352 1.2×	85 0.3×	142 0.6×	187 0.9×	123	2.1k
Jieliang Li China	26	437 0.9×	430 1.4×	145 0.6×	196 0.8×	27 0.1×	78	2.0k
Chien‐Chung Lee Taiwan	24	356 0.7×	303 1.0×	121 0.5×	254 1.1×	128 0.6×	107	1.6k
Jonathan Z. Sexton United States	22	292 0.6×	469 1.6×	142 0.6×	185 0.8×	74 0.4×	63	1.5k
Yingli Chen China	24	352 0.7×	917 3.1×	32 0.1×	412 1.8×	107 0.5×	115	1.9k
Seung–Joo Lee South Korea	23	422 0.9×	347 1.2×	155 0.6×	99 0.4×	35 0.2×	47	1.7k
Hui Xia China	24	136 0.3×	583 2.0×	63 0.3×	468 2.0×	184 0.9×	92	1.8k
Mingxu Hu United States	19	518 1.0×	550 1.8×	87 0.4×	297 1.3×	15 0.1×	55	1.5k

Countries citing papers authored by Ching‐Yuan Wu

Since Specialization

Citations

This map shows the geographic impact of Ching‐Yuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Yuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Yuan Wu more than expected).

Fields of papers citing papers by Ching‐Yuan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Yuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Yuan Wu. The network helps show where Ching‐Yuan Wu may publish in the future.

Co-authorship network of co-authors of Ching‐Yuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Yuan Wu. A scholar is included among the top collaborators of Ching‐Yuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Yuan Wu. Ching‐Yuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Ching‐Yuan, et al.. (2024). The effect and mechanism of astragalus polysaccharides on T cells and macrophages in inhibiting prostate cancer. Biomedical Journal. 48(1). 100741–100741. 3 indexed citations

Wu, Ching‐Yuan, et al.. (2023). Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I. Heliyon. 9(11). e21652–e21652. 4 indexed citations

Wu, Ching‐Yuan, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2023). The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Heliyon. 9(7). e17701–e17701. 2 indexed citations

Yang, Yao‐Hsu, Chia‐Yen Liu, Ming‐Shao Tsai, et al.. (2022). The difference in pathogenic bacteria between chronic rhinosinusitis in patients with and without Sjogren’s syndrome: a retrospective case–control study. BMC Infectious Diseases. 22(1). 666–666. 1 indexed citations

Chang, Geng‐He, Yu‐Ching Cheng, Ching‐Yuan Wu, et al.. (2022). Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway – an in vitro and in clinic study. BMC Complementary Medicine and Therapies. 22(1). 313–313. 5 indexed citations

Tsai, Ming‐Shao, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2022). Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. Biomedicine & Pharmacotherapy. 149. 112802–112802. 9 indexed citations

Chang, Geng‐He, Yu‐Shih Lin, Yu‐Ching Cheng, et al.. (2021). Nasal irrigation with Glycyrrhiza glabra extract for treatment of allergic rhinitis – A study of in vitro, in vivo and clinical trial. Journal of Ethnopharmacology. 275. 114116–114116. 19 indexed citations

Tsai, Ming‐Shao, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2021). GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2. Biomedicine & Pharmacotherapy. 142. 112011–112011. 10 indexed citations

Tsai, Ming‐Shao, Ta‐Jen Lee, Yunting Wang, et al.. (2021). Type 2 Diabetes Mellitus Increases Peritonsillar Abscess Susceptibility: Real-World Evidence. Clinical and Experimental Otorhinolaryngology. 14(3). 347–354. 6 indexed citations

10.

Wu, Ching‐Yuan, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2021). Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomedicine & Pharmacotherapy. 139. 111585–111585. 52 indexed citations

11.

Tsai, Ming‐Shao, Yao‐Hsu Yang, Chia‐Yen Liu, et al.. (2021). Patients with comorbid rheumatoid arthritis are predisposed to peritonsillar abscess: real-world evidence. European Archives of Oto-Rhino-Laryngology. 278(10). 4035–4042. 4 indexed citations

12.

Lung, Jrhau, Yu‐Shih Lin, Yao‐Hsu Yang, et al.. (2020). The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase. Journal of Medical Virology. 92(6). 693–697. 225 indexed citations breakdown →

13.

Wu, Ching‐Yuan, et al.. (2020). GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies. Biomedicine & Pharmacotherapy. 132. 110816–110816. 28 indexed citations

14.

Lin, Yu‐Shih, Ching‐Yuan Wu, Yao‐Hsu Yang, et al.. (2019). Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells. Frontiers in Pharmacology. 10. 1226–1226. 94 indexed citations

15.

Lin, Yu‐Shih, Yao‐Hsu Yang, Chun‐Liang Lin, et al.. (2018). Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway. BMC Complementary and Alternative Medicine. 18(1). 152–152. 32 indexed citations

16.

Chen, Pau‐Chung, et al.. (2015). Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study. BMC Complementary and Alternative Medicine. 15(1). 163–163. 26 indexed citations

17.

Liu, Chun‐Ting, et al.. (2014). Tanshinone IIA Inhibits the Growth of LNCaP Cells by Blocking the Transcriptional Activity of Androgen Receptor. 25(2). 155–165. 1 indexed citations

18.

Yang, Yi-Chien, et al.. (2013). Androgen Receptor Accelerates Premature Senescence of Human Dermal Papilla Cells in Association with DNA Damage. PLoS ONE. 8(11). e79434–e79434. 42 indexed citations

19.

Wu, Ching‐Yuan, et al.. (2011). Cryptotanshinone down‐regulates androgen receptor signaling by modulating lysine‐specific demethylase 1 function. International Journal of Cancer. 131(6). 1423–1434. 47 indexed citations

20.

Fang, Hsin-Yuan, et al.. (2007). Three-dimensional computed tomography for detection of tracheobronchial foreign body aspiration in children. Pediatric Surgery International. 24(2). 157–160. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact